Skip to main content

TuHURA Biosciences, Inc. (HURA) Stock Forecast

Data as of May 9, 2026

Healthcare · Current price $2.35 (-2.08%)

Consensus Target
Upside
Analysts
3
Rating
Buy(2.00)

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

HURA vs Sector & Market

MetricHURAHealthcare AvgLarge Cap Avg
Analyst Rating2.002.242.41
Analyst Count3819
Target Upside+1708.8%+16.4%
P/E Ratio-3.403.3027.60

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$11M$11M$11M3
2027-12-31$34M$34M$34M3
2028-12-31$53M$53M$53M2
2029-12-31$109M$109M$109M1
2030-12-31$166M$166M$166M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.50$-0.45$-0.383
2027-12-31$-0.50$-0.43$-0.362
2028-12-31$-1.35$-0.30$0.752
2029-12-31$0.11$0.11$0.111
2030-12-31$0.52$0.52$0.521

Frequently Asked Questions

What is the analyst consensus for HURA?

The consensus among 3 analysts covering TuHURA Biosciences, Inc. (HURA) is Buy with an average price target of N/A.

How many analysts cover HURA?

3 analysts have issued ratings for TuHURA Biosciences, Inc. in the past 12 months.

Is HURA a buy or sell right now?

Based on 3 analyst ratings, HURA has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.

What are the earnings estimates for HURA?

Analysts estimate HURA will report EPS of $-0.45 for the period ending 2026-12-31, with revenue estimated at $11M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.